Related Experiment Videos
Sequential nephron blockade breaks resistance to diuretics in edematous states
1Medizinische Klinik I, St. Bernward Krankenhaus, Hildesheim, Germany.
Journal of Cardiovascular Pharmacology
|March 1, 1997
Summary
Diuretic resistance in edematous diseases is common. Combining diuretics with acetazolamide effectively overcomes this by targeting increased proximal tubule sodium reabsorption, improving natriuretic response.
Area of Science:
- Nephrology
- Cardiology
- Gastroenterology
Background:
- Edematous diseases like heart failure, cirrhosis, and nephrotic syndrome often show poor response to diuretics.
- Reduced effective arterial blood volume (EABV) is a key characteristic in these conditions.
- Diuretic resistance, a failure to achieve adequate natriuresis, poses a clinical challenge.
Purpose of the Study:
- To investigate the mechanisms of diuretic resistance in edematous states.
- To evaluate different diuretic strategies in patients with reduced EABV.
- To identify predictors of diuretic response.
Main Methods:
- Studied diuretic strategies in patients with congestive heart failure, liver cirrhosis with ascites, and nephrotic syndrome.
- Administered hydrochlorothiazide or furosemide monotherapy.
- Correlated diuretic response with pre-treatment fractional sodium excretion (FENa+).
- Assessed the efficacy of co-administering acetazolamide with diuretics.
Main Results:
- Monotherapy with hydrochlorothiazide or furosemide resulted in inadequate natriuretic response in many patients.
- A low fractional sodium excretion (FENa+ <0.2%) predicted diuretic resistance.
- Coadministration of acetazolamide with diuretic therapy significantly improved the natriuretic response.
Conclusions:
- Increased proximal-tubular sodium reabsorption is a primary cause of diuretic resistance in edematous diseases with functional vascular underfilling.
- Diuretic resistance in these conditions can be effectively overcome by adding a carbonic anhydrase inhibitor, such as acetazolamide.